An Adult Spasticity Registry of OnabotulinumtoxinA Treatment
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms ASPIRE
- Sponsors Allergan
- 20 Apr 2018 According to an Allergan media release, data from this trial will be presented at the 70th Annual American Academy of Neurology (AAN) Meeting 2018.
- 11 Oct 2017 Status changed from active, no longer recruiting to completed.
- 20 Jul 2017 Planned End Date changed from 1 Sep 2017 to 11 Oct 2017.